Category Archives: U.S. Policy and Funding

Brief: Flat funding of biomedical research costs lives, slows progress, hurts economy, and diminishes America’s leadership

By on .

A decade-long trend of diminished investment in medical research, exacerbated by budget-standoff driven “sequester” cuts are showing immediate and long term impacts: in stymieing promising studies, and in thwarting the development of the next generation of scientists, according to a brief from amfAR, the Foundation for AIDS Research and TAG, Treatment Action Group. The brief […]

Congress finalizes FY 2013 budget with PEPFAR cut, Global Fund boost

By on .

The President’s Emergency Plan for AIDS Relief  took a hit while the Global Fund to Fight AIDS, Tuberculosis and Malaria got a boost last week when the House and Senate passed a Continuing Resolution bill to avoid a government shutdown and continue funding the government through Oct. 1, the end of fiscal year 2013. The […]

In lives, health, medical progress, and lost ground — reports tally cost of Budget Control Act

By on .

When legislators went home last week, they left a Continuing Resolution to keep the country running and with it, they left standing the numbers the U.S. Office of Management and Budget cited to estimate the impact of the Budget Control Act’s January 2, 2013 automatic sweeping funding cuts on  government programs, including those responsible for […]